Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain

Author(s): Ya-Qun Zhou, Heng-Yi Gao, Xue-Hai Guan, Xun Yuan, Guang-Guang Fang, Yuan Chen and Da-Wei Ye

Volume 21, Issue 34, 2015

Page: [5029 - 5033] Pages: 5

DOI: 10.2174/1381612821666150831141931

Price: $65

Open Access Journals Promotions 2
Abstract

Bone cancer pain (BCP) is still an intractable problem currently because the analgesic pharmacological intervention remains insufficient. Thus, the development of novel therapeutic target is critical for the treatment of BCP. Emerging evidence demonstrated that some chemokines and their receptors contribute to the induction and maintenance of BCP. In this article, we reviewed the current evidence for the role of different chemokines and their receptors (e.g. CXCL12/CXCR4, CXCL1/CXCR2, CCL2/CCR2, CCL5/CCR5, CX3CL1/CX3CR1 and CXCL10/CXCR3) in mediating BCP. By extensively understanding the involvement of chemokines and their receptors in BCP, novel therapeutic targets may be revealed for the treatment of BCP.

Keywords: Bone cancer pain, chemokine, chemokine receptor, therapeutic target.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy